Biocomposites year of international growth and product advancement

Expansion into new geographies and enhanced approval for STIMULAN to treat bacterial infection

Keele, UK, 15 December 2021 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to provide the following business update.

Read more…

© Optimum Strategic Communications.